UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 223

Sortiert nach

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

Journal of clinical oncology, 2015-09, Vol.33 (27), p.2999-3007

2015

Link zum Volltext

Verfügbarkeit prüfen

Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia

PLoS genetics, 2016-01, Vol.12 (1), p.e1005783-e1005783

2016

Link zum Volltext

Verfügbarkeit prüfen

The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing

Cancer, 2018-08, Vol.124 (16), p.3381-3389

2018

Link zum Volltext

Verfügbarkeit prüfen

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1558-1568

2020

Link zum Volltext

Verfügbarkeit prüfen

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report

Journal of clinical oncology, 2019-10, Vol.37 (30), p.2769-2777

2019

Link zum Volltext

Verfügbarkeit prüfen

Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2

American journal of roentgenology (1976), 2020-05, Vol.214 (5), p.987

2020

Link zum Volltext

Verfügbarkeit prüfen

Disclosing Secondary Findings from Pediatric Sequencing to Families: Considering the "Benefit to Families"

The Journal of law, medicine & ethics, 2015-09, Vol.43 (3), p.552-558

2015

Link zum Volltext

Verfügbarkeit prüfen

A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study

Cancer, 2020-12, Vol.126 (23), p.5156-5164

2020

Link zum Volltext

Verfügbarkeit prüfen

Children's Oncology Group's 2013 blueprint for research: Renal tumors

Pediatric blood & cancer, 2013-06, Vol.60 (6), p.994-1000

2013

Link zum Volltext

Verfügbarkeit prüfen

Hospitalized children continue to report undertreated and preventable pain

Pain research & management, 2014, Vol.19 (4), p.198-204

2014

Link zum Volltext

Verfügbarkeit prüfen

Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia

Nature genetics, 2009-06, Vol.41 (6), p.651-653

2009

Link zum Volltext

Verfügbarkeit prüfen

Germline mutations in MAP3K6 are associated with familial gastric cancer

PLoS genetics, 2014-10, Vol.10 (10), p.e1004669-e1004669

2014

Link zum Volltext

Verfügbarkeit prüfen

Understanding the translation of scientific knowledge about arsenic risk exposure among private well water users in Nova Scotia

The Science of the total environment, 2015-02, Vol.505, p.1259-1273

2015

Link zum Volltext

Verfügbarkeit prüfen

Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting

Genetics in medicine, 2013-07, Vol.15 (7), p.558-564

2013

Link zum Volltext

Verfügbarkeit prüfen

Study of Glycine and Folic Acid Supplementation to Ameliorate Transfusion Dependence in Congenital SLC25A38 Mutated Sideroblastic Anemia

Pediatric blood & cancer, 2016-07, Vol.63 (7), p.1307-1309

2016

Link zum Volltext

Verfügbarkeit prüfen

Ethical Issues for Control-Arm Patients After Revelation of Benefits of Experimental Therapy: A Framework Modeled in Neuroblastoma

Journal of clinical oncology, 2013-02, Vol.31 (5), p.641-646

2013

Link zum Volltext

Verfügbarkeit prüfen

Providing research results to study participants: support versus practice of researchers presenting at the American Society of Hematology annual meeting

Blood, 2005-08, Vol.106 (4), p.1199-1202

2005

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for the Return of Research Results to Study Participants and Guardians: A Report From the Children's Oncology Group

Journal of clinical oncology, 2012-12, Vol.30 (36), p.4573-4579

2012

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533

Journal of clinical oncology, 2022-09, Vol.40 (26), p.3047-3056

2022

Link zum Volltext

Verfügbarkeit prüfen

Parental views on tissue banking in pediatric oncology patients

Pediatric blood & cancer, 2011-12, Vol.57 (7), p.1217-1221

2011

Link zum Volltext

Verfügbarkeit prüfen

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group

Journal of clinical oncology, 2016-09, Vol.34 (26), p.3189-3194

2016

Link zum Volltext

Verfügbarkeit prüfen

Essential medicines for childhood cancer in Europe

The lancet oncology, 2023-02, Vol.24 (2), p.e67-e67

2023

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy and Supportive Care Agents as Essential Medicines for Children With Cancer

JAMA pediatrics, 2019-05, Vol.173 (5), p.477

2019

Link zum Volltext

Verfügbarkeit prüfen

An Ethical Framework for Allocating Scarce Life-Saving Chemotherapy and Supportive Care Drugs for Childhood Cancer

JNCI : Journal of the National Cancer Institute, 2016-06, Vol.108 (6), p.djv392-djv392

2016

Link zum Volltext

Verfügbarkeit prüfen

Novel therapy for pediatric and adolescent kidney cancer

Cancer and metastasis reviews, 2019-12, Vol.38 (4), p.643-655

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 223

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(219)
Mit Volltextzugriff
(197)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia

The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report

Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2

Disclosing Secondary Findings from Pediatric Sequencing to Families: Considering the "Benefit to Families"

A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study

Children's Oncology Group's 2013 blueprint for research: Renal tumors

Hospitalized children continue to report undertreated and preventable pain

Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia

Germline mutations in MAP3K6 are associated with familial gastric cancer

Understanding the translation of scientific knowledge about arsenic risk exposure among private well water users in Nova Scotia

Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting

Study of Glycine and Folic Acid Supplementation to Ameliorate Transfusion Dependence in Congenital SLC25A38 Mutated Sideroblastic Anemia

Ethical Issues for Control-Arm Patients After Revelation of Benefits of Experimental Therapy: A Framework Modeled in Neuroblastoma

Providing research results to study participants: support versus practice of researchers presenting at the American Society of Hematology annual meeting

Recommendations for the Return of Research Results to Study Participants and Guardians: A Report From the Children's Oncology Group

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533

Parental views on tissue banking in pediatric oncology patients

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group

Essential medicines for childhood cancer in Europe

Chemotherapy and Supportive Care Agents as Essential Medicines for Children With Cancer

An Ethical Framework for Allocating Scarce Life-Saving Chemotherapy and Supportive Care Drugs for Childhood Cancer

Novel therapy for pediatric and adolescent kidney cancer

Aktive Filter

Suchergebnisse filtern